CDIF Working Capital Per Revenue	(Dec 31 2024) IV. Quarter	(Sep 30 2024) III. Quarter	(Jun 30 2024) II. Quarter	(Mar 31 2024) I. Quarter	(Dec 31 2023) IV. Quarter
Y / Y Working Capital Change	117.81 %	291.76 %	-	-	-
Y / Y Revenue Change	50.65 %	-60.57 %	-57.75 %	-18.83 %	-19.26 %
Working Capital Per Revenue	0.32	0.34	0.21	0.04	-0.04
Working Capital Per Revenue Ranking	# 1440	# 1891	# 539	# 482	# 0
Seq. Working Capital Change	-29.65 %	-43.79 %	224.21 %	69.9 %	26.53 %
Seq. Revenue Change	130.2 %	-7.88 %	-36.63 %	12.1 %	-39.75 %

New: More CDIF's historic Working Capital Per Revenue Ratios >>

Financial strength information for the Healthcare Facilities industry >> Back to CDIF Financial Strength Comparisons >> See CDIF Balance Sheets

Comment on CDIF's Working Capital Per Revenue in the fourth quarter 2024

Cardiff Lexington's Working Capital Per Revenue in the Q4 2024 sequentially fell to 0.32 but remained above Cardiff Lexington's average.

Within Healthcare sector 18 other companies have achieved lower Working Capital Per Revenue during the Q4 2024. While Cardiff Lexington Working Capital Per Revenue overall ranking has impoved so far in the Q4 2024 to 1440, from total ranking in the third quarter 2024 at 1891.

Working Capital Per Revenue Ranking
Within:	No.
Industry	# 4
Sector	# 19
S&P 500	# 1440

Working Capital Per Revenue Statistics
High	Average	Low
0.32	-1.6	-3.92
(Sep 30 2024)		(Dec 31 2020)

Financial Statements
Cardiff Lexington's Working Capital	$ 2 Millions	Visit CDIF's Balance sheet
Cardiff Lexington's Revenues	$ 3 Millions	Visit CDIF's Income Statement
Where are CDIF's Sales coming from?		Visit CDIF's Sales by Geography

Companies with similar Average Working Capital Per Revenue for 12 months ending Dec 31 2024, within Healthcare Sector	Working Capital Per Revenue
Nanovibronix Inc	0.88
Halozyme Therapeutics Inc	0.88
Castle Biosciences Inc	0.87
Dariohealth Corp	0.87
Glaukos Corp	0.87
Alpha Pro Tech Ltd	0.87
Twist Bioscience Corporation	0.87
Neuropace Inc	0.86
Alpha Teknova Inc	0.86
Hologic Inc	0.85
Mannkind Corporation	0.85
Avita Medical Inc	0.84
Catalyst Pharmaceuticals Inc	0.84
Acutus Medical Inc	0.83
Karyopharm Therapeutics Inc	0.81
Apellis Pharmaceuticals Inc	0.81
Milestone Scientific Inc	0.81
Kindly Md Inc	0.80
Mirum Pharmaceuticals Inc	0.80
Biomarin Pharmaceutical Inc	0.79
Heron Therapeutics Inc	0.78
Lakeland Industries Inc	0.78
Delcath Systems Inc	0.77
10x Genomics Inc	0.76
Scientific Industries Inc	0.76
Axsome Therapeutics Inc	0.76
Caredx Inc	0.74
Qiagen N v	0.74
Edwards Lifesciences Corporation	0.73
Intuitive Surgical Inc	0.70

Date modified: 2025-03-16T19:20:48+00:00

Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com